Clinical TrialsSearch results
Number of results: 237
Other
- Phase II study of ABVd therapy for the previously untreated patients with stage II to IV Hodgkin' s disease (JCOG 9305, LSG14)
- previouly untreated advanced stage Hodgkin lymphoma (stage II, III, IVy)
- Japan Clinical Oncology Group(JCOG)
- 2005-08-30
Other
- Phase II study of ABV with increased dose of adriamycin (ADM) and deleted DTIC followed by adjuvant involved-field radiotherapy (ABV/IFRT) to residual or initial bulky tumor for the previously untreated patients with advanced Hodgkin's disease (stage IB, IIB, III, IV or bulky). (JCOG9705)
- previouly untreated advanced stage Hodgkin lymphoma (stage IB, IIB, III, IV, or bulky)
- Japan Clinical Oncology Group(JCOG)
- 2005-08-18
Other
- Feasibility study of neoadjuvant chemotherapy followed by interval cytoreductive surgery for stage III/IV ovarian, tubal and peritoneal cancers.(JCOG0206, OVCA-NAC-P2)
- stage III/IV ovarian, tubal and peritoneal carcinomas
- Japan Clinical Oncology Group(JCOG)
- 2005-06-07
Other
- Evaluation of feasibility and accuracy of diagnosis using sentinel node biopsy in early gastric cancer(JCOG0302, GCSSG-SNB)
- gastric neoplasm
- Japan Clinical Oncology Group(JCOG)
- 2005-08-15
Other
- Comparative study of neoadjuvant MVAC chemotharapy plus radical systectomy with radical cystectomy alone for imparovent of survival of patients with invasive bladder cancer (T2-4aN0M0)(JCOG0209, BC MVAC Phase III)
- T2-T4aN0M0 invasive bladder cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-08-30
Other
- CHOP therapy for low and low-intermediate risk patients of advanced aggressive non-Hodgkin's lymphoma (JCOG9508, LSG17(CHOP))
- low and low-intermediate risk of aggressive non-Hodgkin's lymphoma
- Japan Clinical Oncology Group(JCOG)
- 2005-08-09
Other
- A Randomized Phase III trial of Paclitaxel plus Cisplatin versus Paclitaxel plus Carboplatin in Stage IVB, Persistent, or Recurrent Cervical Cancer (JCOG0505, CC-TPTC-P3)
- uterine cervical neoplasms
- Japan Clinical Oncology Group(JCOG)
- 2006-02-21
Other
- A PhaseII trial of oral etopocide and iv irinotecan for patients with platinum resistant and taxane pretreated ovarian cancer(JCOG0503)
- platinum resistant and taxane pretreated ovarian cancer
- Japan Clinical Oncology Group(JCOG)
- 2009-04-01
Other
- A phase II study of systemic chemotherapy with TS-1 and CDDP followed by surgery in advanced gastric cancer with extensive lymph node metastasis(JCOG0405)
- gastric neoplasm
- Japan Clinical Oncology Group(JCOG)
- 2005-08-30
Other
- A Phase III Study of Docetaxel and S-1 versus S-1 in the Treatment of Advanced Gastric Cancer
- Gastric Cancer
- Japan Clinical Cancer Research Organization
- 2005-11-01